Vector Laboratories’ blog provides a wealth of information on immunohistochemistry (IHC), immunofluorescence (IF), and related life science research topics.
Christian Bonatto Paese developed a passion for biology as a youth and is now in the midst of a fellowship in the Division of Plastic Surgery at the Cincinnati Children’s Hospital. His goal is to... Read more
Join us as we highlight previous winners of Vector Laboratories Microscopy Image Contest. Experience their scientific artwork and learn how you can become part of the scientific art collective.
Why does glycobiology—the study of sugar chains—matter so much to our health? From the simplest to the most branched, carbohydrates are the key players in cellular functions—both healthy and pathological. This article summarizes the key... Read more
Authority Magazine. An Interview With Charlie Katz. Lisa V Sellers of Vector Laboratories on the five things you need to succeed as a senior executive. Read article
Autofluorescence can make it difficult or impossible to distinguish antigen-specific signal from non-specific background. Learn how you can reduce autofluorescence in your immunofluorescence workflow.
Immunohistochemistry (IHC) is an invaluable technique in a variety of fields—from basic research to clinical diagnosis—but using IHC to screen humanized antibodies in human tissue can be challenging. Learn how scientists are addressing those challenges,... Read more
BURLINGAME, Calif.November 16, 2021 Vector Laboratories, the market leader in the development and manufacture of labeling and detection reagents for biomedical research, today announced that it has promoted Pamela James, Ph.D., to the position of... Read more
Colin Nixon, manager of the Histology core lab at the Beatson Institute for Cancer Research in Glasgow Scotland, failed biology at school and was described by most of his teachers as “academically challenged.” They likely... Read more
Glycosylation networks have massive biomarker potential for breast cancer diagnosis and treatment. This study explores yet another alteration in breast cancer glycan profile: bisecting GlcNAc.
Genetic Engineering & Biotechnology News. The new funding, backed by private equity firm Thompson Street Capital Partners, enables Vector Laboratories to embark upon an acquisition strategy while accelerating the commercialization of innovative labeling and detection technologies for immunohistochemistry, immunofluorescence, glycobiology, and bioconjugation. Read article
